Becton Dickinson and Co (BDX)

Data as of 2026-09-03.

Key facts

Price
187.22 USD
Market capitalisation
$51.8B
P/E ratio
32.2
Dividend yield
2.00%
52-week range
127.59 - 193.07
Beta
0.24
Sector
Health Care
Industry
Health Care
Country
US
Exchange
NEW YORK STOCK EXCHANGE, INC.
Employees
72 000
IPO date
1963-09-25
Analyst price target
201.80 USD
Analyst consensus
10 buy / 11 hold / 0 sell
Stoxly score
60.3 / 100
Universe percentile
better than 88% of the analysed universe

About Becton Dickinson and Co

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.

Website

Similar companies

Full Quality Check for Becton Dickinson and Co

Stoxly scores rate the quality of the published fundamentals, not the upside of the share price. Nothing on this page is investment advice.